Gut microbiome and autoimmune disorders.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

Publication: 2022- : Oxford : Oxford University Press
Original Publication: Oxford : Blackwell Scientific Publications

Autoimmune Diseases* ; Gastrointestinal Microbiome* ; Microbiota*; Dysbiosis ; Humans ; Immune System

Autoimmune diseases have long been known to share a common pathogenesis involving a dysregulated immune system with a failure to recognize self from non-self-antigens. This immune dysregulation is now increasingly understood to be induced by environmental triggers in genetically predisposed individuals. Although several external environmental triggers have been defined in different autoimmune diseases, much attention is being paid to the role of the internal micro-environment occupied by the microbiome, which was once termed "the forgotten organ." In this regard, the gut microbiome, serving as an intermediary between some of those external environmental effectors and the immune system, helps programming of the immune system to be tolerant to innocent external and self-antigens. However, in the presence of perturbed gut microbiota (dysbiosis), the immune system could be erroneously directed in favor of pro-inflammatory pathways to instigate different autoimmune processes. An accumulating body of evidence, including both experimental and human studies (observational and interventional), points to the role of the gut microbiome in different autoimmune diseases. Such evidence could provide a rationale for gut microbiome manipulation with therapeutic and even preventative intent in patients with established or predisposed to autoimmune diseases, respectively. Perturbations of the gut microbiome have been delineated in some immune mediated diseases, IBD in particular. However, such patterns of disturbance (microbiome signatures) and related pathogenetic roles of the gut microbiome are context dependent and cannot be generalized in the same exact way to other autoimmune disorders, and the contribution of the gut microbiome to different disease phenotypes has to be precisely defined. In this review, we revise the evidence for a role of the gut microbiome in various autoimmune diseases and possible mechanisms mediating such a role.
(© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Clin Immunol. 2021 Dec;233:108892. (PMID: 34813937)
Ann Rheum Dis. 2019 Mar;78(3):380-390. (PMID: 30254034)
Pediatrics. 2015 Aug;136(2):e333-43. (PMID: 26195533)
Gut. 2017 Jun;66(6):1039-1048. (PMID: 26843508)
Nature. 2017 Nov 30;551(7682):585-589. (PMID: 29143823)
Curr Opin Toxicol. 2018 Feb;7:22-27. (PMID: 29532040)
Am J Gastroenterol. 1999 Mar;94(3):674-8. (PMID: 10086650)
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15140-15149. (PMID: 31182588)
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10719-10724. (PMID: 28893994)
Nat Clin Pract Gastroenterol Hepatol. 2005 Sep;2(9):416-22. (PMID: 16265432)
Front Biosci. 2003 May 01;8:s533-43. (PMID: 12700052)
J Immunol. 2019 Dec 15;203(12):3199-3208. (PMID: 31732526)
Eur J Immunol. 2015 Sep;45(9):2683-93. (PMID: 26079624)
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. (PMID: 22473917)
Aliment Pharmacol Ther. 2017 Mar;45(5):581-592. (PMID: 28008631)
Frontline Gastroenterol. 2018 Apr;9(2):154-158. (PMID: 29588846)
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3747-58. (PMID: 27415793)
Rheumatology (Oxford). 2020 Jun 1;59(6):1281-1287. (PMID: 31580454)
Arthritis Rheumatol. 2016 Sep;68(9):2151-62. (PMID: 26992013)
J Autoimmun. 2018 Dec;95:47-57. (PMID: 30340822)
Gut Pathog. 2016 Dec 8;8:64. (PMID: 27980687)
Am J Med Sci. 2018 Nov;356(5):424-432. (PMID: 30384951)
Pharmacol Rep. 2014 Apr;66(2):250-5. (PMID: 24911078)
Nat Commun. 2016 Jun 28;7:12015. (PMID: 27352007)
Gut. 2019 Feb;68(2):218-225. (PMID: 29321166)
Autoimmun Rev. 2019 Jun;18(6):607-614. (PMID: 30959217)
Sci Rep. 2016 Apr 05;6:24072. (PMID: 27044888)
Dig Dis Sci. 2008 Sep;53(9):2524-31. (PMID: 18270836)
Elife. 2019 Feb 12;8:. (PMID: 30747106)
Cell Host Microbe. 2019 Jan 9;25(1):113-127.e6. (PMID: 30581114)
Scand J Immunol. 2005 Apr;61(4):301-8. (PMID: 15853911)
Biochem Pharmacol. 2017 Jun 15;134:114-126. (PMID: 27641814)
Cell Host Microbe. 2019 Jul 10;26(1):100-113.e8. (PMID: 31227334)
J Immunol. 2016 Feb 15;196(4):1550-7. (PMID: 26783341)
J Cell Physiol. 2018 Mar;233(3):2091-2103. (PMID: 28294322)
Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S22-5. (PMID: 21586214)
Nat Rev Immunol. 2014 May;14(5):329-42. (PMID: 24751956)
Trends Mol Med. 2020 Sep;26(9):862-873. (PMID: 32402849)
Front Immunol. 2022 Jan 24;12:746998. (PMID: 35140703)
Sci Rep. 2019 Feb 14;9(1):2030. (PMID: 30765731)
J Immunol. 2002 Aug 15;169(4):2189-95. (PMID: 12165549)
PLoS One. 2020 Mar 17;15(3):e0228846. (PMID: 32182248)
Int J Epidemiol. 2018 Oct 1;47(5):1538-1548. (PMID: 29868838)
Diabetologia. 2006 Dec;49(12):2824-7. (PMID: 17028899)
Nutrients. 2018 Aug 03;10(8):. (PMID: 30081517)
J Hepatol. 2016 May;64(5):1049-1057. (PMID: 26723896)
J Immunol. 2009 Nov 15;183(10):6251-61. (PMID: 19864602)
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150. (PMID: 27911839)
Cell Mol Immunol. 2018 Jun;15(6):595-609. (PMID: 29706647)
JAMA Pediatr. 2016 Jan;170(1):20-8. (PMID: 26552054)
Neurology. 2017 Sep 26;89(13):1330-1337. (PMID: 28855411)
Science. 2018 Mar 9;359(6380):1156-1161. (PMID: 29590047)
Gut. 2021 Jan;70(1):92-105. (PMID: 33106354)
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493. (PMID: 28707337)
JAMA Pediatr. 2017 Dec 1;171(12):1217-1225. (PMID: 29052687)
Immunity. 2016 Mar 15;44(3):659-671. (PMID: 26982366)
J Transl Med. 2021 Apr 28;19(1):177. (PMID: 33910577)
Clin Exp Immunol. 2015 Aug;181(2):323-37. (PMID: 25703185)
Curr Opin Rheumatol. 2019 Mar;31(2):201-207. (PMID: 30624285)
Gut. 2019 Jul;68(7):1169-1179. (PMID: 30842211)
Adv Rheumatol. 2019 Mar 18;59(1):12. (PMID: 30885265)
Clin Rev Allergy Immunol. 2012 Feb;42(1):71-8. (PMID: 22109896)
Gastroenterology. 1997 Sep;113(3):802-7. (PMID: 9287971)
Diabetologia. 2006 Jan;49(1):66-70. (PMID: 16344923)
Sci Rep. 2017 Mar 08;7:43662. (PMID: 28272549)
Immunity. 2013 Mar 21;38(3):581-95. (PMID: 23395676)
Clin Exp Gastroenterol. 2014 Dec 09;7:473-87. (PMID: 25525379)
Front Cell Infect Microbiol. 2014 Mar 28;4:39. (PMID: 24734220)
Front Microbiol. 2020 Apr 14;11:628. (PMID: 32346376)
Cell Mol Life Sci. 2019 Oct;76(20):3917-3937. (PMID: 31250035)
Int J Mol Sci. 2020 Dec 21;21(24):. (PMID: 33371435)
Immunol Cell Biol. 2012 Mar;90(3):271-6. (PMID: 22290506)
Clin Exp Immunol. 1994 Apr;96(1):15-9. (PMID: 7512005)
Scand J Gastroenterol. 2008;43(7):831-41. (PMID: 18584522)
Nature. 2011 Oct 26;479(7374):538-41. (PMID: 22031325)
J Clin Res Pediatr Endocrinol. 2020 Jan 28;12(3):303-307. (PMID: 31990165)
Aliment Pharmacol Ther. 2017 Aug;46(4):389-400. (PMID: 28653751)
Science. 2019 Jun 21;364(6446):1179-1184. (PMID: 31221858)
Int J Rheum Dis. 2014 Jun;17(5):519-27. (PMID: 24673738)
Arthritis Rheumatol. 2016 Nov;68(11):2646-2661. (PMID: 27333153)
Arthritis Rheumatol. 2019 Nov;71(11):1858-1868. (PMID: 31106972)
Clin Rheumatol. 2017 Dec;36(12):2697-2707. (PMID: 28914373)
Arch Intern Med. 1990 Sep;150(9):1806-10. (PMID: 2203319)
Curr Med Res Opin. 2005 Aug;21(8):1165-9. (PMID: 16083525)
Clin Nutr. 2017 Oct;36(5):1245-1249. (PMID: 27669638)
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10713-10718. (PMID: 28893978)
Nat Rev Immunol. 2018 Jun;18(6):405-415. (PMID: 29491358)
Diabetes. 2006 May;55(5):1443-9. (PMID: 16644703)
Microbiome. 2017 Jul 11;5(1):73. (PMID: 28697806)
EBioMedicine. 2019 Jun;44:708-715. (PMID: 31151933)
Am J Gastroenterol. 1996 Feb;91(2):328-32. (PMID: 8607501)
J Cell Physiol. 2017 Aug;232(8):1994-2007. (PMID: 27996081)
Immunity. 2010 Jun 25;32(6):815-27. (PMID: 20620945)
ISME J. 2007 May;1(1):56-66. (PMID: 18043614)
Immunity. 2015 Aug 18;43(2):343-53. (PMID: 26287682)
Nat Med. 2016 Jun;22(6):586-97. (PMID: 27158906)
Front Immunol. 2017 May 23;8:598. (PMID: 28588585)
Nat Biotechnol. 2014 Aug;32(8):834-41. (PMID: 24997786)
Intest Res. 2015 Jan;13(1):11-8. (PMID: 25691839)
Dig Liver Dis. 2004 Jan;36(1):35-45. (PMID: 14971814)
J Clin Invest. 2019 Nov 1;129(11):4691-4707. (PMID: 31566580)
Cell Host Microbe. 2019 Dec 11;26(6):764-778.e5. (PMID: 31757768)
Ann Rheum Dis. 2022 Jan;81(1):e3. (PMID: 31924601)
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2916-21. (PMID: 15710870)
Front Microbiol. 2018 Jan 30;9:53. (PMID: 29441048)
Aliment Pharmacol Ther. 2017 Aug;46(3):213-224. (PMID: 28612983)
Front Immunol. 2019 Mar 07;10:385. (PMID: 30899262)
Pediatrics. 2012 Oct;130(4):e794-803. (PMID: 23008454)
Dig Endosc. 2016 Jan;28(1):67-74. (PMID: 26418574)
J Leukoc Biol. 2017 Apr;101(4):893-900. (PMID: 28034915)
Eur J Clin Invest. 2003 May;33(5):397-401. (PMID: 12713453)
Sci Rep. 2017 Oct 20;7(1):13675. (PMID: 29057975)
Immunity. 2016 Apr 19;44(4):875-88. (PMID: 27096318)
Gastroenterol Hepatol (N Y). 2012 Apr;8(4):230-9. (PMID: 22723754)
EBioMedicine. 2019 Oct;48:630-641. (PMID: 31628021)
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21536-21545. (PMID: 32817490)
Aliment Pharmacol Ther. 2018 Jul;48(1):15-34. (PMID: 29722430)
Dig Dis Sci. 2021 Aug;66(8):2700-2711. (PMID: 32681228)
Ann Rheum Dis. 2016 Jun;75(6):1255-61. (PMID: 26209657)
Scand J Gastroenterol. 2000 Nov;35(11):1163-9. (PMID: 11145287)
mBio. 2014 Sep 30;5(5):e01548-14. (PMID: 25271284)
Pediatr Diabetes. 2019 Aug;20(5):574-583. (PMID: 31081243)
Cell. 2020 Jan 23;180(2):221-232. (PMID: 31978342)
Int J Rheum Dis. 2016 Sep;19(9):869-79. (PMID: 27135916)
Mol Med. 2019 Aug 1;25(1):35. (PMID: 31370803)
Front Immunol. 2020 Aug 04;11:1741. (PMID: 32849620)
J Transl Med. 2018 Mar 9;16(1):55. (PMID: 29523156)
J Clin Invest. 2017 Aug 1;127(8):2946-2956. (PMID: 28650341)

Keywords: Gut microbiome; auto-immune diseases; dysbiosis; immune dysregulation

Date Created: 20220602 Date Completed: 20220823 Latest Revision: 20230603

20240628

PMC9390838

10.1093/cei/uxac057

35652460